• LAST PRICE
    0.2700
  • TODAY'S CHANGE (%)
    Trending Down-0.0190 (-6.5679%)
  • Bid / Lots
    0.2701/ 100
  • Ask / Lots
    0.2832/ 350
  • Open / Previous Close
    0.2700 / 0.2890
  • Day Range
    Low 0.2700
    High 0.2700
  • 52 Week Range
    Low 0.1650
    High 0.3150
  • Volume
    300
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 0.27
TimeVolumeEDTXF
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesEDTXF
Spectral Medical Inc
104.0M
-13.0x
---
United StatesBGXX
Bright Green Corp
52.4M
-5.2x
---
United StatesVYNE
Vyne Therapeutics Inc
48.4M
-0.4x
---
United StatesEYEN
Eyenovia Inc
63.1M
-2.1x
---
United StatesJSPR
Jasper Therapeutics Inc
69.7M
-0.7x
---
United StatesODTC
Odonate Inc
43.9M
-0.6x
---
As of 2023-12-04

Company Information

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX has been on the market in many countries outside the United States and has been used in more than 340,000 patients to date. It is engaged in the development of biochemical markers for the clinical syndrome known as septic shock. It is also continuing its legacy business of manufacturing and selling certain reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

Contact Information

Headquarters
135 The West Mall, Unit 2TORONTO, ON, Canada M9C 1C2
Phone
416-626-3233
Fax
416-626-3233

Executives

Non-Executive Independent Chairman of the Board
Anthony Bihl
President, Director
Paul Walker
Chief Executive Officer, Director
Chris Seto
Chief Financial Officer
Blair Mcinnis
Chief Medical Officer
John Kellum

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$77.0M
Revenue (TTM)
$1.3M
Shares Outstanding
278.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.91
EPS
$-0.02
Book Value
$-0.01
P/E Ratio
-13.0x
Price/Sales (TTM)
59.2
Price/Cash Flow (TTM)
---
Operating Margin
-444.31%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.